| Description |
1 online resource (313 p.) |
| Series |
Drugs and the Pharmaceutical Sciences Series |
|
Drugs and the Pharmaceutical Sciences Series
|
| Contents |
Cover -- Half Title -- Series Information -- Title Page -- Copyright Page -- Table of Contents -- Preface -- Editors -- Contributors -- Background -- 1 History of Cancer Therapies -- 1.1 Introduction -- 1.1.1 Hippocrates -- 1.1.2 Post-Hippocratic Period -- 1.1.3 Galen of Pergamon -- 1.1.4 Treatment in Later Era -- 1.2 Cancer Therapy -- 1.2.1 Surgical Treatment -- 1.2.2 Radiation Therapy -- 1.2.3 Chemotherapeutics -- 1.2.3.1 Evolution of Chemotherapy -- 1.2.3.2 Drugs Used in Cancer Treatment -- 1.2.3.3 Combination Therapy -- 1.3 Recent Advances in Cancer Treatment -- 1.3.1 Micelles |
|
1.3.2 Liposomes -- 1.3.3 Nanoparticles -- 1.3.3.1 Types of Nanoparticles -- 1.4 Recent Innovations and Targeted Therapy -- 1.4.1 Monoclonal Antibodies in Tumor Treatment -- 1.4.2 Selective Tyrosine Kinase and Serine/Threonine-Protein Kinase Small Molecules Inhibitors -- 1.4.3 Immune Checkpoint Inhibitors for Tumor Therapy -- 1.4.4 Molecular Radiotherapy in Tumor -- 1.4.5 Use of Nanotechnology in Cancer Treatment Through Gene Therapy -- 1.4.6 Polymeric Nanoparticles as the Targeted Drug Delivery Systems -- 1.4.7 Drug Delivery Through Carbon Nanotubes -- 1.4.8 Drug Delivery Through Nanodiamonds |
|
1.4.9 Radiomics and Patronymics -- 1.4.10 Thermal Ablation and Magnetic Hyperthermia -- 1.5 Conclusion -- References -- 2 Cancer and Carcinogens -- 2.1 Introduction -- 2.1.1 Types of Carcinogens -- 2.1.2 Characteristics of Carcinogens -- 2.2 History of Carcinogens -- 2.3 Routes of Exposure to Carcinogens -- 2.4 Types of Carcinogens -- 2.4.1 Physical Carcinogens -- 2.4.1.1 Fibers -- 2.4.1.2 Non-Fibrous Particulate Material -- 2.4.1.3 Particulate Air Pollution -- 2.4.2 Biological Carcinogens -- 2.4.2.1 Shigella Flexneri -- 2.4.3 Chemical Carcinogens -- 2.4.3.1 Arsenic -- 2.4.3.2 Asbestos |
|
2.4.3.3 4-Aminobiphenyl -- 2.4.3.4 Benzene -- 2.4.3.5 2-Chloroethyl Sulfide -- 2.4.3.6 Cigarette Smoke -- 2.4.4 Environmental Carcinogens -- 2.5 Metabolism of Carcinogens -- 2.6 Detection of Carcinogens -- 2.6.1 32P-Post Labeling Assay -- 2.6.2 Fluorescence Spectroscopy -- 2.6.3 Prevention of Carcinogen Exposure -- 2.7 Conclusion -- References -- 3 Causes of Death From Cancer -- 3.1 Introduction -- 3.2 Causes of Death in the Cancer Patients -- 3.2.1 Hepatic Cancer -- 3.2.2 Lung Cancer -- 3.2.3 Breast Cancer -- 3.2.4 Bone Cancer -- 3.2.5 Tumors of the Gastrointestinal Tract |
|
3.2.6 Ovarian Carcinoma -- 3.2.7 Leukemias -- 3.2.8 Tumors in the Nervous System -- 3.3 Mortality-Provoking Immunosuppression and Metastasis in Cancer -- 3.3.1 Immunosuppression -- 3.3.2 Metastasis -- 3.4 Conclusion -- References -- 4 Passive Targeting -- 4.1 Introduction -- 4.2 Anatomical and Pathophysiological Changes in Tumor Vasculature -- 4.3 Passive Targeting Strategies -- 4.3.1 Formulation Based Strategies -- 4.3.1.1 Size and Shape-Based Targeting -- 4.3.1.2 Surface Modification-Based Targeting -- 4.3.1.3 Charge-Based Targeting -- 4.3.1.4 Stealth-Based Targeting |
| Summary |
This volume in the popular series, Drugs and the Pharmaceutical Sciences, begins with the history of cancer treatment, carcinogens, and molecular mechanisms involved in cancer pathogenesis |
| Notes |
Description based upon print version of record |
|
4.3.1.5 Magnetic-Based Targeting |
| Form |
Electronic book
|
| Author |
Bukhari, Shazia
|
| ISBN |
9781000982930 |
|
1000982939 |
|
